Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer

European Journal of Cancer Part A

Volumn 32, Issue 7, 1996, Pages 1156-1161

  Carpelan Holmstrom M ^a   Haglund, C ^a   Lundin, J ^a   Jarvinen H ^a   Roberts, P ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

CA 242; CEA; colorectal; neoplasm; prognosis; tumour marker

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030176140     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00030-5     Document Type: Article

References (33)

1. 1. Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and adsorption techniques. J Exp Med 1965, 121, 439.
2. 2. Hine KR, Dykes PW. Serum CEA testing in the post-operative surveillance of colorectal carcinoma. Br J Cancer 1984, 49, 689-693.
3. 3. Kuusela P, Haglund C, Roberts PJ. Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. Br J Cancer 1991, 63, 636-640.
4. 4. Martin EW, James KK, Hurtubise PE, Catalano P, Minton JP. The use of CEA as an early indicator of gastrointestinal tumor recurrence and second-look procedures. Cancer 1977, 39, 440-446.
5. 5. Minton JP, Hoehn JL, Gerber DM, et al. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985, 55, 1284-1290.
6. 6. Minton JP, Hoehn JL, Gerber DM, et al. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study. Cancer 1985, 55, 1284-1290.
7. 7. Northover J. Carcinoembryonic antigen and recurrent colorectal cancer. Gut 1986, 27, 117-122.
8. 8. Quentmeier A, Schlag P, Smok M, Herfarth C. Re-operative for recurrent colorectal cancer: the importance of early diagnosis for resectability and survival. Eur J Surg Oncol 1990, 16, 319-325.
9. 9. Roberts PJ. Tumour markers in colorectal cancer. Scand J Gastroenterol 1988, 23, 50-58.
10. 10. Staab HJ, Anderer FA, Stumpf E, Hornung A, Fischer R, Kieninger G. Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer. Am J Surg 1985, 149, 198-204.
11. 11. Sugarbaker PH, Gianola FJ, Dwyer A, Neuman NR. A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery 1987, 102, 79-87.
12. 12. Lindmark G, Bergström R, Påhlman L, Glimelius B. The association of preoperative serum tumour markers with Dukes stage and survival in colorectal cancer. Br J Cancer 1995, 71, 1090-1094.
13. 13. Wang JY, Tang R, Chiang JM. Value of carcinoembryonic antigen in the management of colorectal cancer. Dis Colon Rectum 1994, 37, 272-277.
14. 14. Slentz K, Senagore A, Hibbert J, Mazier WP, Talbott TM. Can preoperative and postoperative CEA predict survival after colon cancer resection? Am Surg 1994, 60, 528-532.
15. 15. Wiggers T, Arends JW, Volovics A. Regression analysis in prognostic factors in colorectal cancer after curative resections. Dis Colon Rectum 1988, 31, 33-41.
16. 16. Brummendorf T, Anderer FA, Staab HJ, Hornung A, Stumpf E, Kieninger G. Prognostic value of preoperative serum CEA level compared to clinical staging: III. An approach to scoring of prognostic factors in colorectal cancer. J Surg Oncol 1985, 28, 263-269.
17. 17. Bogenschutz O, Brummendorf T, Staab HJ, Anderer FA, Kieninger G. Prognostic value of preoperative serum CEA level compared to clinical staging IV. Histological grading and tumor type in colorectal and gastric cancer. J Surg Oncol 1986, 32, 165-173.
18. 18. Dhar P, Moore T, Zamcheck N, Kupchik HZ. Carcinoembryonic antigen (CEA) in colonic cancer. JAMA 1972, 221, 31-35.
19. 19. Wanebo HJ, Rao B, Pinsky CM, et al. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 1978, 299, 448-451.
20. 20. Wolmark N, Fisher B, Wieand HS, Henry RS. The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Ann Surg 1984, 199, 375-382.
21. 21. Staab HJ, Anderer FA, Brummendorf T, Stumpf E, Fischer R. Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal cancer. Br J Cancer 1981, 44, 652-662.
22. 22. Filella X, Molina R, Pique JM, et al. CEA as a prognostic factor in colorectal cancer. Anticancer Res 1994, 14, 705-708.
23. 23. Moertel CG, O'Fallon JR, Go VLW, O'Connell MJ, Th Y, Thynne GS. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer 1986, 58, 603-610.
24. 24. de Mello J, Struthers L, Turner R, et al. Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer. Br J Cancer 1983, 48, 341-348.
25. 25. Steele G, Ellenberg S, Ramming K, et al. CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. Ann Surg 1982, 196, 162-169.
26. 26. Goslin R, Steele G, Macintyre J. The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers. Ann Surg 1980, 192, 747-751.
27. 27. Hohenberger P, Schlag PM, Gerneth T, Herfarth C. Pre-and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Ann Surg 1994, 219, 135-143.
28. 28. Carpelan-Holmström M, Haglund C, Kuusela P, Järvinen H, Roberts PJ. Preoperative serum levels of CEA and CA 242 in colorectal cancer. Br J Cancer 1995, 71, 868-872.
29. 29. Nilsson O, Johansson C, Glimelius B, et al. Sensitivity and specificity of CA 242 in gastrointestinal cancer. A comparison with CEA, CA50 and CA19-9. Br J Cancer 1992, 65, 215-221.
30. 30. Hall NR, Stephenson BM, Purves DA, Cooper EH. The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. Br J Cancer 1994, 70, 549-553.
31. 31. Turnball RB, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technique on survival rates. Ann Surg 1967, 166, 420-127.
32. 32. Deans GT, Parks TG, Rowlands BJ, Spence RAJ. Prognostic factors in colorectal cancer. Br J Surg 1992, 79, 608-613.
33. 33. Jass JR, Atkins WS, Cuzik J, et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 1986, 10, 437-459.